Falsified records, lax oversight, and an experimental PTSD drug from Pfizer, apparently with effects similar to those of January's ill-fated Bial study in France. That was enough for NYU to send psychiatric researcher Alexander Neumeister to the exit door. And only four months after the FDA sent Neumeister a warning letter.
That's fast work, as these things go. Definitely a lot faster than eleven years.